Microscope High-Content Screening (Q3102678): Difference between revisions
Jump to navigation
Jump to search
(Changed an Item: Edited by the beneficiary bot - attach the beneficiary based on the string) |
(Changed label, description and/or aliases in fr: translated_label) |
||
| label / fr | label / fr | ||
Dépistage à haute teneur du microscope | |||
Revision as of 11:44, 27 November 2021
Project Q3102678 in Luxembourg
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Microscope High-Content Screening |
Project Q3102678 in Luxembourg |
Statements
300,000.0 Euro
0 references
750,000.0 Euro
0 references
40.0 percent
0 references
1 November 2018
0 references
1 July 2019
0 references
Luxembourg Institute of Health - LIH
0 references
49°37'54.91"N, 6°3'30.17"E
0 references
The primary goal of the project is to etablish at LIH a fully operational and translational PDM-HCS platform, enabling personalised early drug discovery with a capacity to run a maximum of 10 projects in parallel to meet the many needs of scientific projects conducted in Luxembourg. The LIH platform will provide all academic and industrial scientists in Luxembourg with the opportunity to accelerate their advanced research projects in strategic areas as oncology, infectious disease and neurodegenerative disease. (English)
0 references
Strassen
0 references
Identifiers
21
0 references